ASNC-ACC-Letter-to-Congress_Price-Transparency-Legislation_02-01-2024
In February 2024, ASNC and the American College of Cardiology shared with Senate leaders concerns about the implications of Section 4 of S.3458, the Health Care PRICE Transparency Act 2.0, which posed an unnecessary administrative burden on already strained physician practices and would not have resulted in a patient-centric solution to price transparency. Section 4 would likely have impacted the vast majority of physicians, ranging from small family practices to specialists—all of whom provide imaging services in the office setting.
Resource Type
Health Policy Memos
Related Resources
PET Case: Splenic Switch Off (SSO): A Surrogate of Stress Adequacy
Case summary: This case illustrates the role of splenic switch off as…
PET Case: Abnormal MBFR in Multivessel Spontaneous Coronary Artery Dissection
Case summary: This case illustrates the ability of PET MBFR to detect…
PET Case: Myocardial Infarction with Non-Obstructive Coronary Arteries (MINOCA)
Case summary: This case illustrates the role of multimodality imaging in diagnosing…